Market by Cellulite Type, Procedure Type, End-user, and Regional Outlook | Forecast 2023-2030
Cellulite is termed as the collection of fat that pushes against the
connective tissue beneath the skin. It becomes more visible during aging as the
skin becomes thinner and loses elasticity. Cellulite may be caused by poor
diet, accumulated toxins, genetics, weight gain, pregnancy, and inactivity. In
this regard, cellulite treatment refers to removing subcutaneous fat with
various treatment procedures. The
treatment enhances blood flow, improves body shape, reduces dimpling on the
skin, and improves skin elasticity.
According to Triton Market Research’s analysis, the Global Cellulite Treatment Market is likely to reach $4568.36 million by 2030, from $2225.93 million in 2022, growing with a CAGR of 9.48% during the forecast period 2023 to 2030.
Click here to check out our blog on the Global Cellulite Treatment Market
MARKET PERFORMANCE – DRIVERS,
CHALLENGES, AND OPPORTUNITIES
The rising demand for aesthetic and cosmetic
procedures is expected to drive the cellulite treatment market. As per the American Academy of Facial Plastic
and Reconstructive Surgery (AAFPRS), about 1.4 million facial plastic surgeries
were performed in 2021. In addition, the growing beauty consciousness and
obesity are expected to boost demand for cellulite treatment. Furthermore, the
rising investments in healthcare and personal care and rapid technological
advancements have resulted in a booming medical tourism industry, thereby leading
to market growth.
The market growth of advanced cellulite
treatment is expected to be restricted due to the high price, limited
information about different treatments, and the associated side effects. For instance, radio frequency and lasers may
cause skin irritation. Some serious complications include infection, scarring,
skin inflammation, changes to skin color, and skin abnormalities. Also, in some
cases, retinol cream may cause temporary redness or itchiness.
Nevertheless, advancements in technologies and new product launches are expected to create opportunities for the cellulite treatment market. For instance, radiofrequency therapy has been gaining popularity for cellulite treatment. Furthermore, the rising beauty consciousness and growing demand for minimally invasive and non-invasive procedures, such as anti-cellulite massage, are expected to open avenues for the studied market.
Report scope can be customized per your requirements - Request Free Sample Report
KEY GEOGRAPHIES COVERED:
• North America: United
States and Canada
• Europe: United Kingdom,
France, Germany, Spain, Italy, Nordic Countries, and Rest of Europe
• Asia-Pacific: China,
Japan, India, Australia & New Zealand, South Korea, ASEAN Countries, and
Rest of Asia-Pacific
• Latin America: Brazil,
Mexico, and Rest of Latin America
• Middle East and Africa:
Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle
East & Africa
SEGMENTATION ANALYSIS -
CELLULITE TREATMENT MARKET:
• Market by Cellulite Type:
o Soft
Cellulite
o Edematous
Cellulite
o Hard
Cellulite
Hard cellulite is anticipated to be the
fastest-growing type during the forecast period. Hard cellulite is a severe stage of cellulite,
which can be identified by blemishes on thighs and deep depressions. This gives
off the appearance of an orange peel which is slightly painful.
• Market by Procedure Type:
o Minimally
Invasive
o Topical
o Non-invasive
A
non-invasive procedure is a treatment that does not need incision into the body.
For instance, cryolipolysis is a non-invasive procedure that freezes and kills
fat cells, which are later naturally removed by the body. Similarly, many
treatments use energy from radiofrequency, infrared light, ultrasound, and
others to reduce cellulite.
• Market by End-user:
o Hospitals
o Clinics
and Beauty Centers
o Other
End-users
COMPETITIVE LANDSCAPE:
The cellulite treatment market by company profile helps dive into data
about the key players in this industry. The strategic initiatives for each of
the companies considered have been covered in detail.
Acquisition (January 2022):
Sientra Inc and AuraGen Aesthetic LLC
Sientra acquired novel fat grafting technology from AuraGen Aesthetics,
LLC. The Aura Gen System is used in a broad range of aesthetic specialties for
body contouring.
Product Development (August
2022): AirSculpt Technologies Inc
AirSculpt Technologies launched AirSculpt Smooth, a minimally invasive
cellulite removal technology that offers complete removal of stubborn cellulite
dimples.
Business Expansion (December
2022): Sientra Inc
Sientra received approval from the United Arab Emirates Ministry of
Health and Prevention to market its line of silicone gel breast implants in the
UAE.
KEY BENEFITS OF THE REPORT:
●
Triton Market Research has a collective experience of 25-30 years
in the industry, with its analysts and experts encompassing the most infallible
research methodology for its market intelligence and industry analysis.
●
Our research methodology helps in achieving a broader consensus of
the market size, shape, and industry trends within each industry segment.
●
The strategy adopted in designing the research methodology
includes the amalgamation of the information assembled from primary and
secondary sources, with the assistance of analytical tools to construct the
forecast and predictive models.
●
The scope of the market report comprises the current scenario of
the global cellulite treatment market, along with the detailed overview of the
market outlook, market dynamics, segmentation analysis, regional outlook, and
competitive landscape for the period 2023-2030.
FAQs:
Q 1) What is meant by topical
treatments?
Topical treatments include specialized massage techniques using vacuum
suction or a roller to knead the skin and subcutaneous fat. This also includes
massage options based on the idea that massaging the problem area will increase
blood flow and lower the fat buildup.
Q 2) What is edematous
cellulite?
Edematous cellulite is the most severe form of cellulite associated with
poor blood circulation, aggravated by significant fluid retention. This type of
cellulite is usually apparent on thighs, knees, and lower legs, resulting in
leg swelling.
Market By Category, Applicatio ..
VIEW REPORT
Market by RTD Type | Forecast ..
VIEW REPORT
Market by Product Type | Forec ..
VIEW REPORT
Market by Product, Application ..
VIEW REPORT
Market By Product Type, Specie ..
VIEW REPORT
Market by Ingredient Type, Age ..
VIEW REPORT
Market By Demographics, Produc ..
VIEW REPORT
Market by Type, Sales Channel, ..
VIEW REPORT1. GLOBAL
CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1.PARENT
MARKET ANALYSIS
2.2.IMPACT
ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19
IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA
WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S
FIVE FORCES ANALYSIS
2.3.1.THREAT
OF NEW ENTRANTS
2.3.2.THREAT
OF SUBSTITUTES
2.3.3.BARGAINING
POWER OF BUYERS
2.3.4.BARGAINING
POWER OF SUPPLIERS
2.3.5.THREAT
OF COMPETITIVE RIVALRY
2.4.MARKET
MATURITY ANALYSIS
2.5.INDUSTRY
COMPONENTS
2.5.1.RESEARCH
AND DEVELOPMENT
2.5.2.MANUFACTURING
OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES
MONITORING
2.6.REGULATORY
FRAMEWORK
2.7.KEY
BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND
NAME
2.7.3.USABILITY
2.8.KEY
MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT
LAUNCHES
2.8.3.MERGERS
& ACQUISITIONS
2.8.4.BUSINESS
DIVESTITURES & EXPANSIONS
2.9.MARKET
DRIVERS
2.9.1.GROWING
PREVALENCE OF OBESITY
2.9.2.RAPIDLY
GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING
DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET
CHALLENGES
2.10.1.LACK
OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH
PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS
ASSOCIATED POST-TREATMENT
2.11.MARKET
OPPORTUNITIES
2.11.1.RISING
BEAUTY CONSCIOUSNESS
2.11.2.INCREASING
TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING
DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING
POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS
IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST
PERSPECTIVE
3. GLOBAL
CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT
CELLULITE
3.2.HARD
CELLULITE
3.3.EDEMATOUS
CELLULITE
4. GLOBAL
CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY
INVASIVE
4.3.TOPICAL
5. GLOBAL
CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS
AND BEAUTY CENTERS
5.3.OTHER
END-USERS
6. GLOBAL
CELLULITE TREATMENT MARKET – BY REGIONAL OUTLOOK
6.1.NORTH
AMERICA
6.1.1.MARKET
BY CELLULITE TYPE
6.1.2.MARKET
BY PROCEDURE TYPE
6.1.3.MARKET
BY END-USER
6.1.4.COUNTRY
ANALYSIS
6.1.4.1.UNITED
STATES
6.1.4.1.1.UNITED
STATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.4.2.CANADA
6.1.4.2.1.CANADA
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.EUROPE
6.2.1.MARKET
BY CELLULITE TYPE
6.2.2.MARKET
BY PROCEDURE TYPE
6.2.3.MARKET
BY END-USER
6.2.4.COUNTRY
ANALYSIS
6.2.4.1.UNITED
KINGDOM
6.2.4.1.1.UNITED
KINGDOM CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.2.GERMANY
6.2.4.2.1.GERMANY
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.3.FRANCE
6.2.4.3.1.FRANCE
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.4.ITALY
6.2.4.4.1.ITALY
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.5.SPAIN
6.2.4.5.1.SPAIN
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.6.NORDIC
COUNTRIES
6.2.4.6.1.NORDIC
COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.7.REST
OF EUROPE
6.2.4.7.1.REST
OF EUROPE CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.ASIA-PACIFIC
6.3.1.MARKET
BY CELLULITE TYPE
6.3.2.MARKET
BY PROCEDURE TYPE
6.3.3.MARKET
BY END-USER
6.3.4.COUNTRY
ANALYSIS
6.3.4.1.CHINA
6.3.4.1.1.CHINA
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.2.JAPAN
6.3.4.2.1.JAPAN
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.3.INDIA
6.3.4.3.1.INDIA
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.4.SOUTH
KOREA
6.3.4.4.1.SOUTH
KOREA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.5.ASEAN
COUNTRIES
6.3.4.5.1.ASEAN
COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.6.AUSTRALIA
& NEW ZEALAND
6.3.4.6.1.AUSTRALIA
& NEW ZEALAND CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.7.REST
OF ASIA-PACIFIC
6.3.4.7.1.REST
OF ASIA-PACIFIC CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.4.LATIN
AMERICA
6.4.1.MARKET
BY CELLULITE TYPE
6.4.2.MARKET
BY PROCEDURE TYPE
6.4.3.MARKET
BY END-USER
6.4.4.COUNTRY
ANALYSIS
6.4.4.1.BRAZIL
6.4.4.1.1.BRAZIL
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.4.4.2.MEXICO
6.4.4.2.1.MEXICO
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.4.4.3.REST
OF LATIN AMERICA
6.4.4.3.1.REST
OF LATIN AMERICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.MIDDLE
EAST AND AFRICA
6.5.1.MARKET
BY CELLULITE TYPE
6.5.2.MARKET
BY PROCEDURE TYPE
6.5.3.MARKET
BY END-USER
6.5.4.COUNTRY
ANALYSIS
6.5.4.1.UNITED
ARAB EMIRATES
6.5.4.1.1.UNITED
ARAB EMIRATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.4.2.TURKEY
6.5.4.2.1.TURKEY
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.4.3.SAUDI
ARABIA
6.5.4.3.1.SAUDI
ARABIA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.4.4.SOUTH
AFRICA
6.5.4.4.1.SOUTH
AFRICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.4.5.REST
OF MIDDLE EAST & AFRICA
6.5.4.5.1.REST
OF MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1.1.OVERVIEW
7.1.2.PRODUCT
PORTFOLIO
7.1.3.KEY
STRENGTHS
7.1.4.KEY
CHALLENGES
7.2.ABBVIE
INC
7.2.1.OVERVIEW
7.2.2.PRODUCT
PORTFOLIO
7.2.3.KEY
STRENGTHS
7.2.4.KEY
CHALLENGES
7.3.BAUSCH
HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT
PORTFOLIO
7.3.3.KEY
STRENGTHS
7.3.4.KEY
CHALLENGES
7.4.CUTERA
INC
7.4.1.OVERVIEW
7.4.2.PRODUCT
PORTFOLIO
7.4.3.KEY
STRENGTHS
7.4.4.KEY
CHALLENGES
7.5.INCELER
MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT
PORTFOLIO
7.5.3.KEY
STRENGTHS
7.5.4.KEY
CHALLENGES
7.6.ZIMMER
MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT
PORTFOLIO
7.6.3.KEY
STRENGTHS
7.6.4.KEY
CHALLENGES
7.7.GALDERMA
SA
7.7.1.OVERVIEW
7.7.2.PRODUCT
PORTFOLIO
7.7.3.KEY
STRENGTHS
7.7.4.KEY
CHALLENGES
7.8.SIENTRA
INC
7.8.1.OVERVIEW
7.8.2.PRODUCT
PORTFOLIO
7.8.3.KEY
STRENGTHS
7.8.4.KEY
CHALLENGES
7.9.ENDO
INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT
PORTFOLIO
7.9.3.KEY
STRENGTHS
7.9.4.KEY
CHALLENGES
7.10.CANDELA
MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT
PORTFOLIO
7.10.3.KEY
STRENGTHS
7.10.4.KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1.RESEARCH
SCOPE & DELIVERABLES
8.1.1.OBJECTIVES
OF STUDY
8.1.2.SCOPE
OF STUDY
8.2.SOURCES
OF DATA
8.2.1.PRIMARY
DATA SOURCES
8.2.2.SECONDARY
DATA SOURCES
8.3.RESEARCH
METHODOLOGY
8.3.1.EVALUATION
OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION
OF DATA SOURCES
8.3.3.ASSESSMENT
OF MARKET DETERMINANTS
8.3.4.DATA
COLLECTION
8.3.5.DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL
CELLULITE TREATMENT MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY
FRAMEWORK
TABLE 3: LIST OF
COLLABORATIONS
TABLE 4: LIST OF
PRODUCT LAUNCHES
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: LIST OF
BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: GLOBAL
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: GLOBAL
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: GLOBAL
CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: GLOBAL
CELLULITE TREATMENT MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 12: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 13: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 15: EUROPE
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 16: EUROPE
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 17: EUROPE
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 18: EUROPE
CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 23: LATIN AMERICA
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 24: LATIN AMERICA
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 25: LATIN AMERICA
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 26: LATIN AMERICA
CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 27: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $
MILLION)
TABLE 28: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $
MILLION)
TABLE 29: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $
MILLION)
TABLE 30: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
FIGURE 1: MARKET
MATURITY ANALYSIS
FIGURE 2: INDUSTRY
COMPONENTS
FIGURE 3: KEY BUYING
IMPACT ANALYSIS
FIGURE 4: GLOBAL
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: GLOBAL
CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: GLOBAL
CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: GLOBAL
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: GLOBAL CELLULITE
TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: GLOBAL
CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: GLOBAL
CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: GLOBAL
CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: GLOBAL
CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: GLOBAL
CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $
MILLION)
FIGURE 14: GLOBAL
CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: GLOBAL
CELLULITE TREATMENT MARKET, REGIONAL OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED
STATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: CANADA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: UNITED
KINGDOM CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: GERMANY
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: FRANCE
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: ITALY
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 22: SPAIN
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 23: NORDIC
COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 24: REST OF
EUROPE CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 25: CHINA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 26: JAPAN
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 27: INDIA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 28: SOUTH KOREA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 29: ASEAN
COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 30: AUSTRALIA
& NEW ZEALAND CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 31: REST OF
ASIA-PACIFIC CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 32: BRAZIL
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 33: MEXICO
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 34: REST OF
LATIN AMERICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 35: UNITED ARAB
EMIRATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 36: TURKEY
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 37: SAUDI ARABIA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 38: SOUTH AFRICA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 39: REST OF
MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)